[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Sclerostin pQTL MR",
    "section": "",
    "text": "1 Introduction\nThis code book contains the code used in our comment on “Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization” by Zheng et al. (2023). These analyses use genetic variants in cis of the SOST gene (the gene that encodes sclerostin) that are associated with circulating sclerostin protein levels, known as protein quantitative trait loci (pQTL). We visualize the SOST gene region for each phenotype and perform Mendelian randomization (MR) and colocalization analyses for the cardiovascular events and risk factors tested using results from the same (or equivalent) genome-wide association studies (GWAS) as used by Zheng et al. (2023). Sensitivity Mendelian randomization analyses using European only samples where possible (Section 8.1) and cis sclerostin pQTLs from UK Biobank (Sun et al. 2023) (Section 8.2) were also performed.\nAll of the code was written in  (version 4.3.1). This code book was written using Quarto (version 1.3.433)."
  },
  {
    "objectID": "index.html#installation",
    "href": "index.html#installation",
    "title": "Sclerostin pQTL MR",
    "section": "1.1 Installation",
    "text": "1.1 Installation\nThe data.table and tidyverse packages were used to reading and processing data. The Rsamtools and genetics packages were used to query and process the 1000 Genomes data (1000 Genomes Project Consortium et al. 2015). The geni.plots, heatmaply and reactable packages are used to plot and present the results.\n\ninstall.packages(\"data.table\", dependencies = TRUE)\ninstall.packages(\"tidyverse\")\ninstall.packages(\"genetics\")\ninstall.packages(\"ieugwasr\")\ninstall.packages(\"BiocManager\")\nBiocManager::install(\"Rsamtools\")\ninstall.packages(\"remotes\")\nremotes::install_github(\"jrs95/geni.plots\")\ninstall.packages(\"heatmaply\")\ninstall.packages(\"reactable\")\ninstall.packages(\"downloadthis\")\ninstall.packages(\"tippy\")"
  },
  {
    "objectID": "index.html#libraries",
    "href": "index.html#libraries",
    "title": "Sclerostin pQTL MR",
    "section": "1.2 Libraries",
    "text": "1.2 Libraries\nThe libraries used throughout the code book are dplyr, data.table, geni.plots and reactable. Functions from other libraries are imported as and when needed. Additional functions used in the analyses are stored in ./scripts/00_functions.R and are called using source.\n\nlibrary(data.table)\nlibrary(dplyr)\nlibrary(geni.plots)\nlibrary(reactable)"
  },
  {
    "objectID": "index.html#citation",
    "href": "index.html#citation",
    "title": "Sclerostin pQTL MR",
    "section": "1.3 Citation",
    "text": "1.3 Citation\nStaley JR et al. Genetic data do not provide evidence that lower sclerostin is associated with increased risk of atherosclerosis: comment on the article by Zheng et al. Arthritis Rheumatol 2023; DOI: 10.1002/art.42751"
  },
  {
    "objectID": "index.html#licenses",
    "href": "index.html#licenses",
    "title": "Sclerostin pQTL MR",
    "section": "1.4 Licenses",
    "text": "1.4 Licenses\nThe code is available under the GPL-3 license and the analysis results are available under the CC-BY-4.0 license.\n \n\n\n\n\n\n\n1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature. 2015;526(7571):68.\n\n\nSun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature. 2023;1–10.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "02_data.html#datasets",
    "href": "02_data.html#datasets",
    "title": "2  Data",
    "section": "2.1 Datasets",
    "text": "2.1 Datasets\n\n2.1.1 Sclerostin pQTLs\nThe cis sclerostin pQTLs in Table 2.1 were extracted from Supplementary Table 2 in Zheng et al. (2023).\n\n\n\n\nTable 2.1: cis pQTLs\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nea - effect allele\n\noa - other allele\n\neaf - effect allele frequency\n\nbeta - effect size\nse - standard error of effect size\npvalue - p-pvalue\nn - number of samples\n\n\n\n\n2.1.2 Study information\nThe GWAS studies used in the analyses2 are presented in Table 2.2.3\n\n\n\n\nTable 2.2: GWAS study information\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\nsource - source of dataset\n\npmid - PubMed ID\n\nauthor - author of study\n\nlink - link to dataset\n\ntrait - phenotype\n\nabbr - abbreviation\n\nancestry - ancestry of study\n\nn - number of samples\n\nn_cases - number of cases\n\nn_controls - number of controls\n\nunit - unit of analysis (IRNT = inverse rank normal transformation)\n\nflag - flag if the dataset (or equivalent) was used by Zheng et al. (2023) (Y = yes, N = no)\n\nCitations: Xue et al. (2018); Mahajan et al. (2022); Hartiala et al. (2021); Van Der Harst and Verweij (2018); Aragam et al. (2022); Sudlow et al. (2015); Malik et al. (2018); Mishra et al. (2022); Malhotra et al. (2019); Morris et al. (2019)"
  },
  {
    "objectID": "02_data.html#data-processing",
    "href": "02_data.html#data-processing",
    "title": "2  Data",
    "section": "2.2 Data processing",
    "text": "2.2 Data processing\n\n2.2.1 LD matrix\nThe LD correlation matrix of the SOST region (100KB downstream and 125KB upstream of SOST) for the European samples from 1000 Genomes Phase 3 V5b (1000 Genomes Project Consortium et al. 2015) is computed using the 01_data_ldmat.R R script located in the scripts folder.\n\nsource(\"./scripts/01_data_ldmat.R\")\n\nThe output of the script is an Rda file saved in the data folder as 01_data_ld_mat.Rda which contains two objects:\n\nld_snp - a data.frame of variant information with the columns:\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nref - reference allele\n\nalt - alternate allele\n\naf - allele frequency of the alternate allele\n\nld_mat - a matrix of variant correlations (\\(r\\) not \\(r^2\\))\n\n\n\n2.2.2 GWAS data\n\nSOST region\nThe SOST region is extracted and harmonized from the GWAS datasets using the 02_data_gwas_sos_region.R R script located in the scripts folder. The pQTL dataset is also harmonized using this script. The effect allele is aligned to the alternate allele in ld_snps.\n\nsource(\"./scripts/02_data_gwas_region.R\")\n\nThe output of the script is an Rda file saved in the data folder as 02_data_gwas_sost_region.Rda which contains three objects:\n\ngwas - a data.frame of GWAS results from the studies above with the columns:\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nref - reference allele\n\nalt - alternate allele (effect allele)\n\naf - allele frequency of the alternate allele\n\nbeta - effect size\n\nse - standard error\n\npvalue - p-value\n\npqtls - a data.frame of pQTL results with the columns:\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nref - reference allele\n\nalt - alternate allele (effect allele)\n\naf - allele frequency of the alternate allele\n\nbeta - effect size\n\nse - standard error\n\npvalue - p-value\n\nstudies - a data.frame of GWAS study information with the columns:\n\nid - dataset ID\n\nsource - source of dataset\n\npmid - PubMed ID\n\nauthor - author of study\n\ntrait - phenotype\n\nabbr - abbreviation\n\nancestry - ancestry of study\n\nn - number of samples\n\nn_cases - number of cases\n\nn_controls - number of controls\n\nunit - unit of analysis (IRNT = inverse rank normal transformation)\n\nflag - flag if the dataset (or equivalent) was used by Zheng et al. (2023) (Y = yes, N = no)\n\n\n\n\npQTLs\nThe GWAS results for the sclerostin pQTLs are extracted from 02_data_gwas_sost_region using the 03_data_gwas_pqtls.R R script located in the scripts folder. The associations of rs1107747 and rs4793023 with HDL cholesterol and triglycerides are adjusted for rs72836567 using the COJO methodology (Yang et al. 2012) to account for the effects of the CD300LG gene (see Section 3.2 for further details). No good proxy variants (\\(r^2 \\geq\\) 0.8) were identified for the missing sclerostin pQTLs in GCST006867.\n\nsource(\"./scripts/03_data_gwas_pqtls.R\")\n\nThe output of the script is an Rda file saved in the data folder as 03_data_gwas_pqtls.Rda which contains three objects:\n\ngwas - a data.frame of GWAS results from the studies above with the columns:\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nref - reference allele\n\nalt - alternate allele (effect allele)\n\naf - allele frequency of the alternate allele\n\nbeta - effect size\n\nse - standard error\n\npvalue - p-value\n\npqtls - a data.frame of pQTL results with the columns:\n\nrsid - rsID\n\nchr - chromosome\n\npos - position (build 37)\n\nref - reference allele\n\nalt - alternate allele (effect allele)\n\naf - allele frequency of the alternate allele\n\nbeta - effect size\n\nse - standard error\n\npvalue - p-value\n\nstudies - a data.frame of GWAS study information with the columns:\n\nid - dataset ID\n\nsource - source of dataset\n\npmid - PubMed ID\n\nauthor - author of study\n\ntrait - phenotype\n\nabbr - abbreviation\n\nancestry - ancestry of study\n\nn - number of samples\n\nn_cases - number of cases\n\nn_controls - number of controls\n\nunit - unit of analysis (IRNT = inverse rank normal transformation)\n\nflag - flag if the dataset (or equivalent) was used by Zheng et al. (2023) (Y = yes, N = no)\n\n\n\n\n\n\n\n\n1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature. 2015;526(7571):68.\n\n\nAragam KG, Jiang T, Goel A, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nature Genetics. 2022;54(12):1803–15.\n\n\nHartiala JA, Han Y, Jia Q, et al. Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. European heart journal. 2021;42(9):919–33.\n\n\nKavousi M, Bos MM, Barnes HJ, et al. Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification. medRxiv. 2022;2022–05.\n\n\nMahajan A, Spracklen CN, Zhang W, et al. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nature genetics. 2022;54(5):560–72.\n\n\nMalhotra R, Mauer AC, Lino Cardenas CL, et al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nature genetics. 2019;51(11):1580–7.\n\n\nMalik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature genetics. 2018;50(4):524–37.\n\n\nMalik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. Neurology. 2016;86(13):1217–26.\n\n\nMishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115–23.\n\n\nMorris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nature genetics. 2019;51(2):258–66.\n\n\nSudlow C, Gallacher J, Allen N, et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS medicine. 2015;12(3):e1001779.\n\n\nVan Der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circulation research. 2018;122(3):433–43.\n\n\nXue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nature communications. 2018;9(1):2941.\n\n\nYang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nature genetics. 2012;44(4):369–75.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "02_data.html#footnotes",
    "href": "02_data.html#footnotes",
    "title": "2  Data",
    "section": "",
    "text": "An extra 25KB was added upstream to ensure that all relevant CD300LG variants are included in the region.↩︎\nThe ischemic and cardioembolic stroke GWAS results from METASTROKE (Malik et al. 2016) used by Zheng et al. (2023) were replaced with those from MEGASTROKE (Malik et al. 2018) and the UK Biobank hypertension GWAS results from OpenGWAS used by Zheng et al. (2023) were replaced with those from Pan-UKBB due to licensing restrictions. The GWAS of coronary artery calcification was not available (either publicly or via application) at the time of this analysis (Kavousi et al. 2022).↩︎\nSince Zheng et al. (2023) use trans-ethnic GWAS results, we followed suit. In all of the trans-ethnic analyses the majority of the samples were from European ancestry. There was no material difference in the results if we restricted the analyses to analysing Europeans only where possible Section 8.1.↩︎"
  },
  {
    "objectID": "03_ld_matrix.html#data",
    "href": "03_ld_matrix.html#data",
    "title": "3  LD matrix",
    "section": "3.1 Data",
    "text": "3.1 Data\n\n# pQTLs\npqtls &lt;- fread(\n  \"./data/00_data_pqtls.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\n\n# LD matrix\nload(\"./data/01_data_ldmat.Rda\")"
  },
  {
    "objectID": "03_ld_matrix.html#sec-ldmat",
    "href": "03_ld_matrix.html#sec-ldmat",
    "title": "3  LD matrix",
    "section": "3.2 LD matrix",
    "text": "3.2 LD matrix\n\nSclerostin pQTLsSclerostin pQTLs and CD300LG variants\n\n\n\n# LD matrix for pQTLs\nld_mat_pqtls &lt;- ld_mat[\n  match(pqtls$rsid, rownames(ld_mat)),\n  match(pqtls$rsid, colnames(ld_mat)),\n  drop = FALSE\n]\n\n# Compute r2 from r\nld_mat_pqtls &lt;- round(ld_mat_pqtls^2, 3)\n\n# Heatmap\nheatmaply::heatmaply(\n  ld_mat_pqtls,\n  label_names = c(\"Variant 1\", \"Variant 2\", \"r2\"),\n  row_dend_left = TRUE,\n  key.title = \"r2\"\n)\n\n\n\n\nFigure 3.1: LD matrix sclerostin pQTLs\n\n\n\n\n\nSince CD300LG located nearby to SOST is known to be associated with HDL cholesterol and triglycerides, we examined whether any of the sclerostin pQTLs are in LD with either rs72836561 (a functional variant in CD300LG known to be associated with HDL cholesterol and triglycerides (Surakka et al. 2015)) and / or rs72836567 (the top associated variant with CD300LG expression in GTEx (GTEx Consortium 2020)). Two of the sclerostin pQTLs (rs1107747 & rs4793023) are mildly correlated (\\(r^2\\) &gt; 0.05) with rs72836567. So, for these sclerostin pQTLs we used rs72836567 to adjust out any residual association with HDL cholesterol and triglycerides due to the effects of the CD300LG gene (Yang et al. 2012).\n\n# LD matrix for pQTLs and CD300LG variants\nld_mat_pqtls_cd300lg &lt;- ld_mat[\n  match(c(pqtls$rsid, \"rs72836561\", \"rs72836567\"), rownames(ld_mat)),\n  match(c(pqtls$rsid, \"rs72836561\", \"rs72836567\"), colnames(ld_mat)),\n  drop = FALSE\n]\n\n# Compute r2 from r\nld_mat_pqtls_cd300lg &lt;- round(ld_mat_pqtls_cd300lg^2, 3)\n\n# CD300LG correlations\nld_mat_pqtls_cd300lg &lt;- ld_mat_pqtls_cd300lg[\n  pqtls$rsid,\n  c(\"rs72836561\", \"rs72836567\"),\n  drop = FALSE\n]\n\n# Heatmap\nheatmaply::heatmaply(\n  ld_mat_pqtls_cd300lg,\n  dendrogram = \"none\",\n  label_names = c(\"Sclerostin pQTL\", \"CD300LG variant\", \"r2\"),\n  limits = c(0, 1),\n  key.title = \"r2\"\n)\n\n\n\n\nFigure 3.2: LD matrix sclerostin pQTLs and CD300LG variants\n\n\n\n\n\n\n\n\n\n\n\n\nGTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318–30.\n\n\nSurakka I, Horikoshi M, Mägi R, et al. The impact of low-frequency and rare variants on lipid levels. Nature genetics. 2015;47(6):589–97.\n\n\nYang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nature genetics. 2012;44(4):369–75."
  },
  {
    "objectID": "04_sost_assoc.html#original-datasets",
    "href": "04_sost_assoc.html#original-datasets",
    "title": "4  SOST region associations",
    "section": "4.1 Original datasets",
    "text": "4.1 Original datasets\nGenetic associations in the SOST region for the datasets in Table tbl-gwas-study-info that were analysed by Zheng et al. (2023) (or equivalent2).\n\nMICADISCEST2DHTNAACLDLHDLTGAPOAAPOBFRACBMD\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST011365\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.1: Regional plot of the SOST region for myocardial infarction (GCST011365)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST011365\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.2: QQ plot of the SOST region for myocardial infarction (GCST011365)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005194\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.3: Regional plot of the SOST region for coronary artery disease (GCST005194)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005194\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.4: QQ plot of the SOST region for coronary artery disease (GCST005194)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005843\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.5: Regional plot of the SOST region for ischemic stroke (GCST005843)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005843\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.6: QQ plot of the SOST region for ischemic stroke (GCST005843)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005842\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.7: Regional plot of the SOST region for cardioembolic stroke (GCST005842)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST005842\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.8: QQ plot of the SOST region for cardioembolic stroke (GCST005842)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006867\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs1107747\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.9: Regional plot of the SOST region for type 2 diabetes (GCST006867)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006867\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.10: QQ plot of the SOST region for type 2 diabetes (GCST006867)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB200021065\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.11: Regional plot of the SOST region for hypertension (UKB200021065)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB200021065\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.12: QQ plot of the SOST region for hypertension (UKB200021065)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"PHS000930AAC\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.13: Regional plot of the SOST region for abdominal aortic calcification (PHS000930AAC)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"PHS000930AAC\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.14: QQ plot of the SOST region for abdominal aortic calcification (PHS000930AAC)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30780\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.15: Regional plot of the SOST region for LDL cholesterol (UKB30780)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30780\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.16: QQ plot of the SOST region for LDL cholesterol (UKB30780)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30760\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\",\n    highlights_label = FALSE\n  )\n\n\n\n\nFigure 4.17: Regional plot of the SOST region for HDL cholesterol (UKB30760)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30760\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.18: QQ plot of the SOST region for HDL cholesterol (UKB30760)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30870\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\",\n    highlights_label = FALSE\n  )\n\n\n\n\nFigure 4.19: Regional plot of the SOST region for triglycerides (UKB30870)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30870\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.20: QQ plot of the SOST region for triglycerides (UKB30870)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30630\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\",\n    highlights_label = FALSE\n  )\n\n\n\n\nFigure 4.21: Regional plot of the SOST region for apolipoprotein A-I (UKB30630)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30630\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.22: QQ plot of the SOST region for apolipoprotein A-I (UKB30630)\n\n\n\nNote: rs72836561 is a missense variant in CD300LG that is known to be associated with lipid profiles (Surakka et al. 2015).\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30640\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.23: Regional plot of the SOST region for apolipoprotein B (UKB30640)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"UKB30640\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.24: QQ plot of the SOST region for apolipoprotein B (UKB30640)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006980\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.25: Regional plot of the SOST region for fracture (GCST006980)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006980\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.26: QQ plot of the SOST region for fracture (GCST006980)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006979\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.27: Regional plot of the SOST region for heel bone mineral density (GCST006979)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST006979\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.28: QQ plot of the SOST region for heel bone mineral density (GCST006979)"
  },
  {
    "objectID": "04_sost_assoc.html#additional-datasets",
    "href": "04_sost_assoc.html#additional-datasets",
    "title": "4  SOST region associations",
    "section": "4.2 Additional datasets",
    "text": "4.2 Additional datasets\nGenetic associations in the SOST region for the additional recent GWAS datasets in Table tbl-gwas-study-info.\n\nCADISCESLASSVST2D\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90132315\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.29: Regional plot of the SOST region for coronary artery disease (GCST90132315)\n\n\n\nNote: the allele of rs851058 associated with lower coronary artery disease risk is also associated with lower mRNA expression of the SOST in GTEx (GTEx Consortium 2020) and higher bone mineral density (Morris et al. 2019).\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90132315\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.30: QQ plot of the SOST region for coronary artery disease (GCST90132315)\n\n\n\nNote: the allele of rs851058 associated with lower coronary artery disease risk is also associated with lower mRNA expression of the SOST in GTEx (GTEx Consortium 2020) and higher bone mineral density (Morris et al. 2019).\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104535\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.31: Regional plot of the SOST region for ischemic stroke (GCST90104535)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104535\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.32: QQ plot of the SOST region for ischemic stroke (GCST90104535)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104536\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.33: Regional plot of the SOST region for cardioembolic stroke (GCST90104536)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104536\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.34: QQ plot of the SOST region for cardioembolic stroke (GCST90104536)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104538\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.35: Regional plot of the SOST region for large artery stroke (GCST90104538)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104538\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.36: QQ plot of the SOST region for large artery stroke (GCST90104538)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104537\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.37: Regional plot of the SOST region for small vessel stroke (GCST90104537)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90104537\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.38: QQ plot of the SOST region for small vessel stroke (GCST90104537)\n\n\n\n\n\n\n\n\n\nRegional plotQQ plot\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90132183\") %&gt;%\n  regional_plot(\n    data = .,\n    corr = ld_mat,\n    top_marker = \"rs66838809\",\n    highlights = pqtls$rsid,\n    highlights_title = \"Sclerostin associated variants\"\n  )\n\n\n\n\nFigure 4.39: Regional plot of the SOST region for type 2 diabetes (GCST90132183)\n\n\n\n\n\n\ngwas %&gt;%\n  filter(id == \"GCST90132183\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 4.40: QQ plot of the SOST region for type 2 diabetes (GCST90132183)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nGTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369(6509):1318–30.\n\n\nKavousi M, Bos MM, Barnes HJ, et al. Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification. medRxiv. 2022;2022–05.\n\n\nMalik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature genetics. 2018;50(4):524–37.\n\n\nMalik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. Neurology. 2016;86(13):1217–26.\n\n\nMorris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nature genetics. 2019;51(2):258–66.\n\n\nSurakka I, Horikoshi M, Mägi R, et al. The impact of low-frequency and rare variants on lipid levels. Nature genetics. 2015;47(6):589–97.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "04_sost_assoc.html#footnotes",
    "href": "04_sost_assoc.html#footnotes",
    "title": "4  SOST region associations",
    "section": "",
    "text": "The red and green dashed lines in the regional plots are the p-value thresholds \\(1 \\times 10^{-6}\\) (regional-wide significance threshold used in Zheng et al. (2023)) and \\(5 \\times 10^{-8}\\) (genome-wide significance threshold), respectively.↩︎\nThe ischemic and cardioembolic stroke GWAS results from METASTROKE (Malik et al. 2016) used by Zheng et al. (2023) were replaced with those from MEGASTROKE (Malik et al. 2018) and the UK Biobank hypertension GWAS results from OpenGWAS used by Zheng et al. (2023) were replaced with those from Pan-UKBB due to licensing restrictions. The GWAS of coronary artery calcification was not available either publicly or via application at the time of this analysis (Kavousi et al. 2022).↩︎"
  },
  {
    "objectID": "05_pqtl_assoc.html#original-datasets",
    "href": "05_pqtl_assoc.html#original-datasets",
    "title": "5  Sclerostin pQTL associations",
    "section": "5.1 Original datasets",
    "text": "5.1 Original datasets\nGenetic associations of the sclerostin pQTLs with cardiovascular events and risk factors in the datasets in Table 2.2 that were analysed by Zheng et al. (2023) (or equivalent1).\n\nAssociationsQQ plot\n\n\n\nassoc &lt;- gwas %&gt;%\n  filter(flag == \"Y\" & !(id %in% c(\"GCST006979\", \"GCST006980\"))) %&gt;%\n  select(id, pmid, trait, n, n_cases, rsid, pvalue) %&gt;%\n  arrange(pvalue)\n\n\n\n\n\nTable 5.1: GWAS associations with sclerostin pQTLs (original datasets)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nqq_plot(assoc)\n\n\n\n\nFigure 5.1: QQ plot of GWAS associations with sclerostin pQTLs (original datasets)"
  },
  {
    "objectID": "05_pqtl_assoc.html#additional-datasets",
    "href": "05_pqtl_assoc.html#additional-datasets",
    "title": "5  Sclerostin pQTL associations",
    "section": "5.2 Additional datasets",
    "text": "5.2 Additional datasets\nGenetic associations of the sclerostin pQTLs with cardiovascular events and risk factors in the additional recent GWAS datasets in Table 2.2.\n\nAssociationsQQ plot\n\n\n\nassoc_add &lt;- gwas %&gt;%\n  filter(flag == \"N\") %&gt;%\n  select(id, pmid, trait, n, n_cases, rsid, pvalue) %&gt;%\n  arrange(pvalue)\n\n\n\n\n\nTable 5.2: GWAS associations with sclerostin pQTLs (additional datasets)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nqq_plot(assoc_add)\n\n\n\n\nFigure 5.2: QQ plot of GWAS associations with sclerostin pQTLs (additional datasets)\n\n\n\n\n\n\n\n\n\n\n\n\nKavousi M, Bos MM, Barnes HJ, et al. Multi-ancestry genome-wide analysis identifies effector genes and druggable pathways for coronary artery calcification. medRxiv. 2022;2022–05.\n\n\nMalik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nature genetics. 2018;50(4):524–37.\n\n\nMalik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. Neurology. 2016;86(13):1217–26.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "05_pqtl_assoc.html#footnotes",
    "href": "05_pqtl_assoc.html#footnotes",
    "title": "5  Sclerostin pQTL associations",
    "section": "",
    "text": "The ischemic and cardioembolic stroke GWAS results from METASTROKE (Malik et al. 2016) used by Zheng et al. (2023) were replaced with those from MEGASTROKE (Malik et al. 2018) and the UK Biobank hypertension GWAS results from OpenGWAS used by Zheng et al. (2023) were replaced with those from Pan-UKBB due to licensing restrictions. The GWAS of coronary artery calcification was not available either publicly or via application at the time of this analysis (Kavousi et al. 2022).↩︎"
  },
  {
    "objectID": "06_mr.html#data",
    "href": "06_mr.html#data",
    "title": "6  Mendelian randomization",
    "section": "6.1 Data",
    "text": "6.1 Data\n\n# Data\nload(\"./data/01_data_ldmat.Rda\")\nload(\"./data/03_data_gwas_pqtls.Rda\")\n\n# pQTLs\npqtls &lt;- pqtls %&gt;%\n  mutate(\n    ld_cluster = if_else(\n      rsid %in% c(\"rs66838809\", \"rs80107551\", \"rs76449013\"),\n      1,\n      2\n    )\n  )\n\n# GWAS\ngwas &lt;- gwas %&gt;%\n  filter(!(id %in% c(\"GCST006979\", \"GCST006980\")))"
  },
  {
    "objectID": "06_mr.html#sec-mr",
    "href": "06_mr.html#sec-mr",
    "title": "6  Mendelian randomization",
    "section": "6.2 Analyses",
    "text": "6.2 Analyses\nMendelian randomization (MR) analyses of circulating sclerostin against cardiovascular events and risk factors were performed using the datasets in Table 2.2. The cis sclerostin pQTLs were used as the genetic instruments and two variant sets were used: (i) all 5 cis sclerostin pQTLs, and (ii) one cis sclerostin pQTL from each LD cluster (i.e., rs668388091 & rs1107747; Section 3.2). Since the sclerostin pQTLs are correlated, the generalized inverse-weighted method (Burgess et al. 2016) was used to perform the MR analyses.\n\n# MR analyses\nmr_results &lt;- tibble()\nfor (id in unique(gwas$id)) {\n\n  ## MR data\n  mr_gwas &lt;- gwas %&gt;%\n    filter(id == !!id) %&gt;%\n    inner_join(\n      x = pqtls,\n      y = .,\n      by = c(\"rsid\", \"chr\", \"pos\", \"ref\", \"alt\")\n    ) %&gt;%\n    relocate(id, .before = rsid)\n\n  ## MR analysis\n  for (j in seq_len(2)) {\n\n    ### Data\n    if (j == 1) {\n      mr_data &lt;- mr_gwas\n      mr_corr &lt;- ld_mat[\n        match(mr_data$rsid, rownames(ld_mat)),\n        match(mr_data$rsid, rownames(ld_mat)),\n        drop = FALSE\n      ]\n      mr_model &lt;- \"5_cis_pqtls\"\n    } else {\n      mr_data &lt;- mr_gwas %&gt;%\n        arrange(pvalue.x) %&gt;%\n        distinct(ld_cluster, .keep_all = TRUE)\n      mr_corr &lt;- ld_mat[\n        match(mr_data$rsid, rownames(ld_mat)),\n        match(mr_data$rsid, rownames(ld_mat)),\n        drop = FALSE\n      ]\n      mr_model &lt;- \"2_cis_pqtls\"\n    }\n    if (any(mr_data$rsid != rownames(mr_corr)))\n      stop(\"genetic varaints are not aligned between the GWAS data and the LD matrix\")\n\n    ### Input\n    mr_inputs &lt;- MendelianRandomization::mr_input(\n      bx = mr_data$beta.x,\n      bxse = mr_data$se.x,\n      by = mr_data$beta.y,\n      byse = mr_data$se.y,\n      correlation = mr_corr,\n      snps = mr_data$rsid\n    )\n\n    ### Analysis\n    mr_analysis &lt;- MendelianRandomization::mr_ivw(\n      mr_inputs,\n      model = \"fixed\",\n      correl = TRUE\n    )\n    mr_analysis &lt;- tibble(\n      id = !!id,\n      model = !!mr_model,\n      n_snps = !!nrow(mr_data),\n      beta = -1 * !!round(mr_analysis$Estimate, 6), # per lower SD sclerostin\n      se = !!round(mr_analysis$StdError, 6),\n      pvalue = !!signif(mr_analysis$Pvalue, 4)\n    )\n\n    ### Results\n    mr_results &lt;- mr_results %&gt;%\n      bind_rows(mr_analysis)\n\n  }\n\n}\n\n# MR results\nmr_results &lt;- studies %&gt;%\n  select(id, pmid, trait, n, n_cases) %&gt;%\n  inner_join(\n    x = .,\n    y = mr_results,\n    by = \"id\"\n  )\n\nAdditional MR analyses of hypertension2, stroke events3 and coronary artery calcification were extracted from Table 2 in Zheng et al. (2023) and added to the results.\n\n# MR analyses extra\nmr_results_extra &lt;- fread(\n  \"./data/00_data_mr.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\nmr_studies_extra &lt;- fread(\n  \"./data/00_data_mr_studies.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\n\n# MR results\nmr_results &lt;- mr_studies_extra %&gt;%\n  select(id, pmid, trait, n, n_cases) %&gt;%\n  inner_join(\n    x = .,\n    y = mr_results_extra,\n    by = \"id\"\n  ) %&gt;%\n  bind_rows(mr_results, .)\n\n# MR studies\nmr_studies &lt;- studies %&gt;%\n  bind_rows(mr_studies_extra)\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\npmid - PubMed ID\n\ntrait - phenotype\n\nn - number of samples\n\nn_cases - number of cases\n\nmodel - MR model\n\nn_snps - number of SNPs\n\nbeta - MR effect size (per SD lower sclerostin)\n\nse - MR standard error\n\npvalue - MR p-value"
  },
  {
    "objectID": "06_mr.html#results",
    "href": "06_mr.html#results",
    "title": "6  Mendelian randomization",
    "section": "6.3 Results",
    "text": "6.3 Results\n\nAssociationsQQ plots\n\n\n\n\n\n\nTable 6.1: MR results of the effect of per SD lower sclerostin on cardiovascular events and risk factors\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n : Effect (in SD)\n : Odds ratio\n\n\n\nOriginal datasetsAdditional datasets\n\n\n\n2 cis pQTLs5 cis pQTLs\n\n\n\nmr_results %&gt;%\n  filter(model == \"2_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"Y\") %&gt;%\n  distinct(trait, .keep_all = TRUE) %&gt;%\n  qq_plot()\n\n\n\n\nFigure 6.1: QQ plot of MR results (2 cis pQTLs) for the original datasets\n\n\n\n\n\n\nmr_results %&gt;%\n  filter(model == \"5_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"Y\") %&gt;%\n  distinct(trait, .keep_all = TRUE) %&gt;%\n  qq_plot()\n\n\n\n\nFigure 6.2: QQ plot of MR results (5 cis pQTLs) for the original datasets\n\n\n\n\n\n\n\n\n\n2 cis pQTLs5 cis pQTLs\n\n\n\nmr_results %&gt;%\n  filter(model == \"2_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"N\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 6.3: QQ plot of MR results (2 cis pQTLs) for the additional datasets\n\n\n\n\n\n\nmr_results %&gt;%\n  filter(model == \"5_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"N\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 6.4: QQ plot of MR results (5 cis pQTLs) for the additional datasets\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBurgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in mendelian randomization: Comparison of allele score and summarized data methods. Statistics in medicine. 2016;35(11):1880–906.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "06_mr.html#footnotes",
    "href": "06_mr.html#footnotes",
    "title": "6  Mendelian randomization",
    "section": "",
    "text": "rs66838809 was not available in GCST006867, so rs80107551 was used instead.↩︎\nThe hypertension results were transformed from the risk difference scale to the log-odds scale.↩︎\nThese stroke analyses use rs1107747 and a proxy of rs80107551.↩︎"
  },
  {
    "objectID": "07_coloc.html#data",
    "href": "07_coloc.html#data",
    "title": "7  Colocalization analyses",
    "section": "7.1 Data",
    "text": "7.1 Data\nThese results were extracted from Supplementary Table 10 in Zheng et al. (2023).2\n\n# Data\ncoloc_table &lt;- fread(\n  \"./data/00_data_coloc.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\n\n# Process\ncoloc_table &lt;- coloc_table %&gt;%\n  as_tibble() %&gt;%\n  mutate(\n    across(starts_with(\"pph\"), ~ round(.x, 4))\n  ) %&gt;%\n  filter(!(id %in% c(\"GCST006979\", \"GCST006980\"))) # drop results with fracture and bone mineral density\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\npmid - PubMed ID\n\ntrait - phenotype\n\nn - number of samples\n\nn_cases - number of cases\n\nn_snps - number of SNPs\n\npph0 - probability that there is no genetic signal with either sclerostin levels or the phenotype in the SOST region\n\npph1 - probability that there is a genetic signal with sclerostin levels in the SOST region but not with the phenotype\n\npph2 - probability that there is a genetic signal with phenotype in the SOST region but not with sclerostin levels\n\npph3 - probability that there is a genetic signal with both sclerostin levels and the phenotype in the SOST region but these signals are independent (i.e., they are not the same)\n\npph4 - probability that there is a shared genetic signal between sclerostin levels and the phenotype in the SOST region"
  },
  {
    "objectID": "07_coloc.html#results",
    "href": "07_coloc.html#results",
    "title": "7  Colocalization analyses",
    "section": "7.2 Results",
    "text": "7.2 Results\n\n\n\n\nTable 7.1: Colocalization results of sclerostin with the phenotypes tested in the SOST region (Zheng et al. 2023)"
  },
  {
    "objectID": "07_coloc.html#additional-analyses",
    "href": "07_coloc.html#additional-analyses",
    "title": "7  Colocalization analyses",
    "section": "7.3 Additional analyses",
    "text": "7.3 Additional analyses\n\n7.3.1 Data\n\n# Data\nload(\"./data/01_data_ldmat.Rda\")\nload(\"./data/02_data_gwas_sost_region.Rda\")\n\n## pQTLs\npqtls &lt;- pqtls %&gt;%\n  arrange(pvalue)\n\n## GWAS\ngwas &lt;- gwas %&gt;%\n  filter(\n    (\n      !grepl(\"^UKB3\", id) &\n        chr == \"17\" &\n        pos &gt;= 41831099 - 100000 &\n        pos &lt;= 41836156 + 100000\n    ) |\n      grepl(\"^UKB3\", id) # keep additional CD300LG variants only for lipid measures\n  ) %&gt;%\n  mutate(z = round(beta / se, 6)) %&gt;%\n  filter(!is.na(z) & !is.na(se))\n\nSince we only had access to the top associated sclerostin pQTLs in the SOST region, we imputed the circulating sclerostin associations in the SOST region using each pQTL. These imputed associations were then used in the colocalization analyses (Giambartolomei et al. 2014).3\n\n# Impute pQTL data\npqtls_impute &lt;- list()\nfor (rsid in pqtls$rsid) {\n  pqtls_impute[[rsid]] &lt;- gwas_impute(\n    data = pqtls %&gt;%\n      filter(rsid == !!rsid) %&gt;%\n      rename(oa = ref, ea = alt, eaf = af),\n    snpinfo = ld_snps,\n    corr = ld_mat,\n    n = 29381\n  ) %&gt;%\n    mutate(z = round(beta / se, 6)) %&gt;%\n    filter(!is.na(z) & !is.na(se))\n}\n\n\n\n7.3.2 Analyses\n\n# Colocalization analyses\ncoloc_results &lt;- tibble()\nfor (id in unique(gwas$id)) {\n\n  ## Colocalization pQTLs\n  for (rsid in pqtls$rsid) {\n\n    ### Colocalization data\n    coloc_data &lt;- gwas %&gt;%\n      filter(id == !!id) %&gt;%\n      inner_join(\n        x = pqtls_impute[[rsid]],\n        y = .,\n        by = c(\"rsid\", \"chr\", \"pos\", \"ref\", \"alt\"),\n        suffix = c(\"_1\", \"_2\")\n      ) %&gt;%\n      relocate(id, .before = rsid)\n\n    ### Colocalization Bayes factors\n    bf1 &lt;- coloc_bf(\n      z = coloc_data$z_1,\n      v = coloc_data$se_1^2\n    )\n    bf2 &lt;- coloc_bf(\n      z = coloc_data$z_2,\n      v = coloc_data$se_2^2,\n      binary = !(\n        studies %&gt;%\n          filter(id == !!id) %&gt;%\n          pull(n_cases) %&gt;%\n          is.na(.)\n      )\n    )\n\n    ### Colocalization analysis\n    coloc_analysis &lt;- coloc(bf1, bf2) %&gt;%\n      round(., 4) %&gt;%\n      t(.) %&gt;%\n      as_tibble() %&gt;%\n      mutate(\n        id = !!id,\n        pqtl = !!rsid,\n        n_snps = !!nrow(coloc_data)\n      ) %&gt;%\n      relocate(id, n_snps, pqtl, .before = 1)\n\n    ### Colocalization results\n    coloc_results &lt;- coloc_results %&gt;%\n      bind_rows(coloc_analysis)\n\n  }\n\n}\n\n\ncoloc_results &lt;- coloc_results %&gt;%\n  inner_join(\n    x = select(studies, id, pmid, trait, n, n_cases),\n    y = .,\n    by = \"id\"\n  )\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\npmid - PubMed ID\n\ntrait - phenotype\n\nn - number of samples\n\nn_cases - number of cases\n\nn_snps - number of SNPs\n\npqtl - pQTL used to impute the sclerostin genetic associations in the SOST region\n\npph0 - probability that there is no genetic signal with either sclerostin levels or the phenotype in the SOST region\n\npph1 - probability that there is a genetic signal with sclerostin levels in the SOST region but not with the phenotype\n\npph2 - probability that there is a genetic signal with phenotype in the SOST region but not with sclerostin levels\n\npph3 - probability that there is a genetic signal with both sclerostin levels and the phenotype in the SOST region but these genetic signals are independent (i.e., they are not the same)\n\npph4 - probability that there is a shared genetic signal between sclerostin levels and the phenotype in the SOST region\n\n\n\n\n7.3.3 Results\n\n\n\n\nTable 7.2: Colocalization results of sclerostin with the phenotypes tested in the SOST region\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFoley CN, Staley JR, Breen PG, et al. A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits. Nature communications. 2021;12(1):764.\n\n\nGiambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS genetics. 2014;10(5):e1004383.\n\n\nWallace C. A more accurate method for colocalisation analysis allowing for multiple causal variants. PLoS genetics. 2021;17(9):e1009440.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "07_coloc.html#footnotes",
    "href": "07_coloc.html#footnotes",
    "title": "7  Colocalization analyses",
    "section": "",
    "text": "This model assumes that there is at most one genetic signal for circulating sclerostin and the phenotype in the SOST region. This assumption is satisfied for the sclerostin pQTLs because we impute the associations in the SOST region based on each pQTL. Similar results were also found when relaxing this assumption for the phenotypes combining fine-mapping and colocalization approaches (Wallace 2021), with only the genetic signals of heel bone mineral density and fracture colocalizing with the genetic signals of circulating sclerostin in the SOST region (\\(P(H4)\\) &gt; 0.8).↩︎\nThe SOST region was defined as 500kb either side of the SOST.↩︎\nThe prior probabilities were set to p1 = 1e-4, p2 = 1e-4 and p12 = 2e-6 (Giambartolomei et al. 2014; Foley et al. 2021).↩︎"
  },
  {
    "objectID": "08_sensitivity.html#sec-mr-eur",
    "href": "08_sensitivity.html#sec-mr-eur",
    "title": "8  Sensitivity analyses",
    "section": "8.1 European only analyses",
    "text": "8.1 European only analyses\nThe same Mendelian randomization analyses as in sec-mr were performed using European only samples (where available).\n\n# MR analyses\nmr_results &lt;- fread(\n  \"./data/00_data_sensitivity_eur_mr.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\nmr_studies &lt;- fread(\n  \"./data/00_data_sensitivity_eur_mr_studies.tsv\",\n  header = TRUE, data.table = FALSE, sep = \"\\t\"\n)\n\n# MR results\nmr_results &lt;- mr_studies %&gt;%\n  select(id, pmid, trait, n, n_cases) %&gt;%\n  inner_join(\n    x = .,\n    y = mr_results,\n    by = \"id\"\n  )\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\npmid - PubMed ID\n\ntrait - phenotype\n\nn - number of samples\n\nn_cases - number of cases\n\nmodel - MR model\n\nn_snps - number of SNPs\n\nbeta - MR effect size (per SD lower sclerostin)\n\nse - MR standard error\n\npvalue - MR p-value\n\n\n\n8.1.1 Results\n\nAssociationsQQ plots\n\n\n\n\n\n\nTable 8.1: MR results of the effect of per SD lower sclerostin on cardiovascular events and risk factors\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n : Effect (in SD)\n : Odds ratio\n\n\n\nOriginal datasetsAdditional datasets\n\n\n\n2 cis pQTLs5 cis pQTLs\n\n\n\nmr_results %&gt;%\n  filter(model == \"2_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"Y\") %&gt;%\n  distinct(trait, .keep_all = TRUE) %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.1: QQ plot of MR results (2 cis pQTLs) for the original datasets\n\n\n\n\n\n\nmr_results %&gt;%\n  filter(model == \"5_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"Y\") %&gt;%\n  distinct(trait, .keep_all = TRUE) %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.2: QQ plot of MR results (5 cis pQTLs) for the original datasets\n\n\n\n\n\n\n\n\n\n2 cis pQTLs5 cis pQTLs\n\n\n\nmr_results %&gt;%\n  filter(model == \"2_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"N\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.3: QQ plot of MR results (2 cis pQTLs) for the additional datasets\n\n\n\n\n\n\nmr_results %&gt;%\n  filter(model == \"5_cis_pqtls\") %&gt;%\n  inner_join(\n    x = select(mr_studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"N\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.4: QQ plot of MR results (5 cis pQTLs) for the additional datasets"
  },
  {
    "objectID": "08_sensitivity.html#sec-mr-ukbb",
    "href": "08_sensitivity.html#sec-mr-ukbb",
    "title": "8  Sensitivity analyses",
    "section": "8.2 UK Biobank sclerostin pQTLs",
    "text": "8.2 UK Biobank sclerostin pQTLs\nGenetic variant associations with circulating sclerostin in the SOST region from UK Biobank using the Olink platform were obtained from Sun et al. (2023). Sclerostin pQTLs in cis of SOST (±100KB) were defined using LD clumping using LDlinkR setting \\(r^2 &lt; 0.2\\) (Myers et al. 2020). Three sclerostin pQTLs were identified rs1513671, rs80107551 (this variant was included in the Zheng et al. (2023) sclerostin pQTLs) and rs865429. These sclerostin pQTLs were used to perform the same Mendelian randomization analyses as in sec-mr using the Zheng et al. (2023) sclerostin pQTLs.\n\nsource(\"./scripts/04_data_ukbb_pqtls_region.R\")\nsource(\"./scripts/05_data_ukbb_pqtls.R\")\nsource(\"./scripts/06_data_gwas_ukbb_pqtls.R\")\n\n\n8.2.1 Data\n\n# Data\nload(\"./data/01_data_ldmat.Rda\")\nload(\"./data/06_data_gwas_ukbb_pqtls.Rda\")\n\n# GWAS\ngwas &lt;- gwas %&gt;%\n  filter(!(id %in% c(\"GCST006979\", \"GCST006980\")))\n\n\n\n8.2.2 Analyses\nMendelian randomization (MR) analyses of circulating sclerostin against cardiovascular events and risk factors were performed using the datasets in Table tbl-gwas-study-info. The cis sclerostin pQTLs from UK Biobank were used as the genetic instruments. Since the sclerostin pQTLs are correlated, the generalized inverse-weighted method (Burgess et al. 2016) was used to perform the MR analyses.\n\n# MR analyses\nmr_results &lt;- tibble()\nfor (id in unique(gwas$id)) {\n\n  ## MR data\n\n  ### GWAS\n  mr_data &lt;- gwas %&gt;%\n    filter(id == !!id) %&gt;%\n    inner_join(\n      x = pqtls,\n      y = .,\n      by = c(\"rsid\", \"chr\", \"pos\", \"ref\", \"alt\")\n    ) %&gt;%\n    relocate(id, .before = rsid)\n\n  ### LD matrix\n  mr_corr &lt;- ld_mat[\n    match(mr_data$rsid, rownames(ld_mat)),\n    match(mr_data$rsid, rownames(ld_mat)),\n    drop = FALSE\n  ]\n  if (any(mr_data$rsid != rownames(mr_corr)))\n    stop(\"genetic varaints are not aligned between the GWAS data and the LD matrix\")\n\n  ## MR analysis\n\n  ### Input\n  mr_inputs &lt;- MendelianRandomization::mr_input(\n    bx = mr_data$beta.x,\n    bxse = mr_data$se.x,\n    by = mr_data$beta.y,\n    byse = mr_data$se.y,\n    correlation = mr_corr,\n    snps = mr_data$rsid\n  )\n\n  ### Analysis\n  mr_analysis &lt;- MendelianRandomization::mr_ivw(\n    mr_inputs,\n    model = \"fixed\",\n    correl = TRUE\n  )\n  mr_analysis &lt;- tibble(\n    id = !!id,\n    model = \"UKBB cis pQTLs\",\n    n_snps = !!nrow(mr_data),\n    beta = -1 * !!round(mr_analysis$Estimate, 6), # per lower SD sclerostin\n    se = !!round(mr_analysis$StdError, 6),\n    pvalue = !!signif(mr_analysis$Pvalue, 4)\n  )\n\n  ### Results\n  mr_results &lt;- mr_results %&gt;%\n    bind_rows(mr_analysis)\n\n}\n\n# MR results\nmr_results &lt;- studies %&gt;%\n  select(id, pmid, trait, n, n_cases) %&gt;%\n  inner_join(\n    x = .,\n    y = mr_results,\n    by = \"id\"\n  )\n\n\n\n Download as xlsx\n\n\n\n\nREADME\n\n\nid - dataset ID\n\npmid - PubMed ID\n\ntrait - phenotype\n\nn - number of samples\n\nn_cases - number of cases\n\nmodel - MR model\n\nn_snps - number of SNPs\n\nbeta - MR effect size (per SD lower sclerostin)\n\nse - MR standard error\n\npvalue - MR p-value\n\n\n\n\n8.2.3 Results\n\nAssociationsQQ plots\n\n\n\n\n\n\nTable 8.2: MR results of the effect of per SD lower sclerostin on cardiovascular events and risk factors\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n : Effect (in SD)\n : Odds ratio\n\n\n\nOriginal datasetsAdditional datasets\n\n\n\nmr_results %&gt;%\n  inner_join(\n    x = select(studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"Y\") %&gt;%\n  distinct(trait, .keep_all = TRUE) %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.5: QQ plot of MR results for the original datasets\n\n\n\n\n\n\nmr_results %&gt;%\n  inner_join(\n    x = select(studies, id, flag),\n    y = .,\n    by = \"id\"\n  ) %&gt;%\n  filter(flag == \"N\") %&gt;%\n  qq_plot()\n\n\n\n\nFigure 8.6: QQ plot of MR results or the additional datasets\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBurgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in mendelian randomization: Comparison of allele score and summarized data methods. Statistics in medicine. 2016;35(11):1880–906.\n\n\nMyers TA, Chanock SJ, Machiela MJ. LDlinkR: An r package for rapidly calculating linkage disequilibrium statistics in diverse populations. Frontiers in genetics. 2020;11:157.\n\n\nSun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with genetics and health in the UK biobank. Nature. 2023;1–10.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating sclerostin may increase risk of atherosclerosis and its risk factors: Evidence from a genome-wide association meta-analysis followed by mendelian randomization. Arthritis & Rheumatology. 2023;75(10):1781–92."
  },
  {
    "objectID": "09_references.html",
    "href": "09_references.html",
    "title": "References",
    "section": "",
    "text": "1000 Genomes Project Consortium et al. A global reference for human\ngenetic variation. Nature. 2015;526(7571):68.\n\n\nAragam KG, Jiang T, Goel A, et al. Discovery and systematic\ncharacterization of risk variants and genes for coronary artery disease\nin over a million participants. Nature Genetics. 2022;54(12):1803–15.\n\n\nBurgess S, Dudbridge F, Thompson SG. Combining information on multiple\ninstrumental variables in mendelian randomization: Comparison of allele\nscore and summarized data methods. Statistics in medicine.\n2016;35(11):1880–906.\n\n\nFoley CN, Staley JR, Breen PG, et al. A fast and efficient\ncolocalization algorithm for identifying shared genetic risk factors\nacross multiple traits. Nature communications. 2021;12(1):764.\n\n\nGiambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for\ncolocalisation between pairs of genetic association studies using\nsummary statistics. PLoS genetics. 2014;10(5):e1004383.\n\n\nGTEx Consortium. The GTEx consortium atlas of genetic regulatory effects\nacross human tissues. Science. 2020;369(6509):1318–30.\n\n\nHartiala JA, Han Y, Jia Q, et al. Genome-wide analysis identifies novel\nsusceptibility loci for myocardial infarction. European heart journal.\n2021;42(9):919–33.\n\n\nKavousi M, Bos MM, Barnes HJ, et al. Multi-ancestry genome-wide analysis\nidentifies effector genes and druggable pathways for coronary artery\ncalcification. medRxiv. 2022;2022–05.\n\n\nMahajan A, Spracklen CN, Zhang W, et al. Multi-ancestry genetic study of\ntype 2 diabetes highlights the power of diverse populations for\ndiscovery and translation. Nature genetics. 2022;54(5):560–72.\n\n\nMalhotra R, Mauer AC, Lino Cardenas CL, et al. HDAC9 is implicated in\natherosclerotic aortic calcification and affects vascular smooth muscle\ncell phenotype. Nature genetics. 2019;51(11):1580–7.\n\n\nMalik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide\nassociation study of 520,000 subjects identifies 32 loci associated with\nstroke and stroke subtypes. Nature genetics. 2018;50(4):524–37.\n\n\nMalik R, Traylor M, Pulit SL, et al. Low-frequency and common genetic\nvariation in ischemic stroke: The METASTROKE collaboration. Neurology.\n2016;86(13):1217–26.\n\n\nMishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug\ndiscovery and risk prediction across ancestries. Nature.\n2022;611(7934):115–23.\n\n\nMorris JA, Kemp JP, Youlten SE, et al. An atlas of genetic influences on\nosteoporosis in humans and mice. Nature genetics. 2019;51(2):258–66.\n\n\nMyers TA, Chanock SJ, Machiela MJ. LDlinkR: An r package for rapidly\ncalculating linkage disequilibrium statistics in diverse populations.\nFrontiers in genetics. 2020;11:157.\n\n\nPsaty BM, O’donnell CJ, Gudnason V, et al. Cohorts for heart and aging\nresearch in genomic epidemiology (CHARGE) consortium: Design of\nprospective meta-analyses of genome-wide association studies from 5\ncohorts. Circulation: Cardiovascular Genetics. 2009;2(1):73–80.\n\n\nSudlow C, Gallacher J, Allen N, et al. UK biobank: An open access\nresource for identifying the causes of a wide range of complex diseases\nof middle and old age. PLoS medicine. 2015;12(3):e1001779.\n\n\nSun BB, Chiou J, Traylor M, et al. Plasma proteomic associations with\ngenetics and health in the UK biobank. Nature. 2023;1–10.\n\n\nSurakka I, Horikoshi M, Mägi R, et al. The impact of low-frequency and\nrare variants on lipid levels. Nature genetics. 2015;47(6):589–97.\n\n\nVan Der Harst P, Verweij N. Identification of 64 novel genetic loci\nprovides an expanded view on the genetic architecture of coronary artery\ndisease. Circulation research. 2018;122(3):433–43.\n\n\nWallace C. A more accurate method for colocalisation analysis allowing\nfor multiple causal variants. PLoS genetics. 2021;17(9):e1009440.\n\n\nXue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143\nrisk variants and putative regulatory mechanisms for type 2 diabetes.\nNature communications. 2018;9(1):2941.\n\n\nYang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP\nanalysis of GWAS summary statistics identifies additional variants\ninfluencing complex traits. Nature genetics. 2012;44(4):369–75.\n\n\nZheng J, Wheeler E, Pietzner M, et al. Lowering of circulating\nsclerostin may increase risk of atherosclerosis and its risk factors:\nEvidence from a genome-wide association meta-analysis followed by\nmendelian randomization. Arthritis & Rheumatology.\n2023;75(10):1781–92."
  },
  {
    "objectID": "10_ackowledgements.html#megastoke",
    "href": "10_ackowledgements.html#megastoke",
    "title": "Acknowledgements",
    "section": "MEGASTOKE",
    "text": "MEGASTOKE\nThe MEGASTROKE project received funding from sources specified at http://www.megastroke.org/acknowledgments.html."
  },
  {
    "objectID": "10_ackowledgements.html#charge",
    "href": "10_ackowledgements.html#charge",
    "title": "Acknowledgements",
    "section": "CHARGE",
    "text": "CHARGE\nThe GWAS results for abdominal aortic calcification were downloaded from CHARGE via dbGaP (accession: phs000930.v10.p1; application: #35610).\nThe authors acknowledge the essential role of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium (Psaty et al. 2009) in the development and support of this research (see http://web.chargeconsortium.com for more details). The authors thank the investigators, the staff, and the participants of each contributing cohort in the CHARGE consortium publication from which these results were obtained.\nSupport for the CHARGE consortium infrastructure was provided by the NIH grant R01 HL105756 (B Psaty). Support for establishing and curation of the dbGaP CHARGE Summary site (phs000930) was provided by the University of Virginia."
  },
  {
    "objectID": "10_ackowledgements.html#pan-ukbb",
    "href": "10_ackowledgements.html#pan-ukbb",
    "title": "Acknowledgements",
    "section": "Pan-UKBB",
    "text": "Pan-UKBB\nPan-UKB team. https://pan.ukbb.broadinstitute.org. 2020.\n\n\n\n\n\n\nPsaty BM, O’donnell CJ, Gudnason V, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circulation: Cardiovascular Genetics. 2009;2(1):73–80."
  },
  {
    "objectID": "11_acroynms.html",
    "href": "11_acroynms.html",
    "title": "Acronyms",
    "section": "",
    "text": "GWAS - genome-wide association study\n\nLD - linkage disequilibrium\n\nMR - Mendelian randomization\n\nOR - odds ratio\n\npQTL - protein quantitative trait loci\n\nQQ - quantile-quantile\n\nSD - standard deviation"
  }
]